Engineered virus platform
Newcastle disease virus
Newcastle disease virus replicates preferentially in tumor cells and has a strong record as an oncolytic and immunostimulatory agent in research settings. FuBio propagates NDV vectors carrying reporter genes for replication tracking.
-
Intrinsic tumor selectivity
Defective interferon responses in tumor cells favor NDV replication.
-
Reporter constructs
GFP-carrying NDV for direct visualization of infection and spread.
-
Immunostimulatory profile
Strong type I interferon induction, relevant to combination immunotherapy research.
-
Propagation and titration
Amplification in embryonated eggs or cell culture with titer determination.
Typical applications
- Oncolytic virus efficacy screening
- Innate immune response research
- Combination studies with immune checkpoint research tools
- Viral replication tracking in vitro and in vivo
Specifications
- Catalog constructs
- Reporter-carrying NDV available
- Volume
- 1 mL
- Promoter
- Endogenous NDV promoter
- Custom engineering
- Transgene insertion on request
Others in Oncolytic Virus
-
Oncolytic adenovirus
Oncolytic adenoviruses are the most widely used oncolytic platform. FuBio supplies adenoviral constructs with...
-
Herpes simplex virus
Herpes simplex virus type 1 offers a large genome and a well-characterized replication cycle, which makes it...
-
Vesicular stomatitis virus
Vesicular stomatitis virus is a fast-replicating, cytoplasmically replicating vector widely used to study...
Need a specification or a quotation?
Send the vector, payload and scale you need. We reply with feasibility, lead time and price within one business day.